The Boston Globe on ran a story on Senate Finance Committee Chair Chuck Grassley (R-Iowa) and his role as the driving force behind a congressional charge to change FDA. According to the Globe article, Grassley has “exposed internal FDA memos, emails and conversations to unprecedented public scrutiny” in his attempts to “prod the agency to […]
GTC Biotherapeutics, a company specializing in the development of therapeutics derived from transgenic animals, has reason to be optimistic. Investing 20 years in the business of developing transgenically derived treatments, the company suffered a recent setback in February when European officials denied approval of a transgenically produced drug. However, the Committee for Medicinal Products for […]
The San Francisco Business Times ran an article reiterating what patent practitioners already know. That is, the increasing backlog at the U.S. Patent & Trademark Office is bad, it’s getting worse and the new set of proposals meant to reduce the waiting time will not provide relief. The backlogs are an increasingly serious issue for […]
In Falker-Gunter Falkner et al. v. Inglis et al. (Fed. Cir. 2006, 05-1324), on appeal from the USPTO Board of Patent Appeals and Interferences, the U.S. Court of Appeals for the Federal Circuit set out some guidelines on the adequacy of written description and enablement in biotech cases. The Federal Circuit held that: (1) examples […]
Apparently after making substantial campaign contributions, the Baristas from Patent Baristas have been named Blawgers of the Year in the 2006 TechnoLawyer @ Awards! There’s no cash prize but it beats a poke in the eye. Of course, it’s an honor to just be nominated. It just happens to be even better to win. Blawgger […]
We’ve been quite busy these days and so posting has been light as a result. Since I have a personal interest in getting my own workload reduced a little, I wanted to pass along that my firm is currently looking to hire on new IP attorneys. The Position: Patent Associate with at least one year […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
